Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients (2007)
- Authors:
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; DOREA, EGIDIO LIMA - HU ; BERNIK, MARCIA MARTINS SILVEIRA - HU
- Unidades: FCF; HU
- Subjects: HIPERCOLESTEROLEMIA; EXPRESSÃO GÊNICA; FARMACOGENÉTICA
- Language: Inglês
- Imprenta:
- Publisher: International Pharmaceutical Federation
- Publisher place: Amsterdam
- Date published: 2007
- Source:
- Título: Abstracts
- Conference titles: World Congress of the Board of Pharmaceutical Sciences of FIP
-
ABNT
ARAZI, Simone Sorkin et al. Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients. 2007, Anais.. Amsterdam: International Pharmaceutical Federation, 2007. . Acesso em: 15 fev. 2026. -
APA
Arazi, S. S., Willrich, M. A. V., Dalla-Vecchia, F., Hirata, M. H., Dorea, E. L., Bernik, M. M. S., & Hirata, R. D. C. (2007). Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients. In Abstracts. Amsterdam: International Pharmaceutical Federation. -
NLM
Arazi SS, Willrich MAV, Dalla-Vecchia F, Hirata MH, Dorea EL, Bernik MMS, Hirata RDC. Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients. Abstracts. 2007 ;[citado 2026 fev. 15 ] -
Vancouver
Arazi SS, Willrich MAV, Dalla-Vecchia F, Hirata MH, Dorea EL, Bernik MMS, Hirata RDC. Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients. Abstracts. 2007 ;[citado 2026 fev. 15 ] - Polimorfismos no receptor scavenger classe B tipo I e sua relação com perfil sérico e resposta a atorvastatina em indivíduos brasileiros
- Association between polymorphism of the hepatic uptake transporter SLCO1B1 and reduced atrovastatin response
- Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals
- mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy
- CYP3A5 polymorphism is associated with differences on gene expression and cholesterol-lowering response to atorvastatin
- Alteration of the expression of efflux and uptake transporters during hypercholesterolemia. Role in variability of atorvastatin response
- Estudo da expressão gênica e polimorfismos da CYP3A5 em indivíduos hipercolesterolêmicos tratados com atorvastatina
- Variants in S1P and ABCG1 genes are novel independent risk factors for dyslipidemia
- Efeito da atorvastatina sobre os genes SREBF1, SREBF2 e SCAP em pacientes hipercolesterolêmicos
- Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
